BioSpecifics Technologies Corp. | Ownership
Companies that own BioSpecifics Technologies Corp.
Renaissance Technologies LLC
526,900
7.22%
24,900
0.03%
06/30/2018
Stonepine Capital Management LLC
461,315
6.32%
-128,710
14.24%
06/30/2018
BlackRock Fund Advisors
333,172
4.57%
34,110
0%
06/30/2018
Dimensional Fund Advisors LP
271,262
3.72%
1,612
0%
06/30/2018
The Vanguard Group, Inc.
248,628
3.41%
7,442
0%
06/30/2018
Rice, Hall, James & Associates LLC
204,183
2.8%
42,429
0.37%
06/30/2018
Elk Creek Partners LLC
161,839
2.22%
-3,246
0.44%
06/30/2018
Thomson, Horstmann & Bryant, Inc.
113,935
1.56%
67,565
0.71%
06/30/2018
Acadian Asset Management LLC
110,934
1.52%
1,806
0.02%
06/30/2018
SSgA Funds Management, Inc.
102,589
1.41%
3,222
0%
06/30/2018
| Address |
35 Wilbur Street
Lynbrook New York 11563
United States
|
|
Employees
|
- |
| Website |
http://www.biospecifics.com |
| Updated |
07/08/2019 |
| BioSpecifics Technologies Corp. engages in the development of an injectable collagenase for multiple indications. Its products include XIAFLEX, which is a treatment used for Dupuytren's contracture. The company was founded in 1990 and is headquartered in Lynbrook, NY. |
